Dexmedetomidine Combined With Hydromorphone in Tonsillectomy and Adenoidectomy

Sponsor
Eye & ENT Hospital of Fudan University (Other)
Overall Status
Completed
CT.gov ID
NCT03760809
Collaborator
(none)
130
1
2
2.9
45.5

Study Details

Study Description

Brief Summary

Tonsillectomy and adenoidectomy is one of the most common pediatric surgeries, and agitation and severe postoperative pain have been considered a very common complications. Dexmedetomidine mainly inhibits the release of norepinephrine by acting on the α-adrenergic receptor of the brainstem nucleus, which can produce good sedative effects. Hydromorphone has a longer duration of action than fentanyl, and it also has a certain sedative effect. The combination of the two is more conducive to the management of postanesthetic agitation and pain. This study was to compare the effect of different doses of dexmedetomidine combined with hydromorphone in the sedation and analgesia after pediatric tonsillectomy and adenoidectomy.

Condition or Disease Intervention/Treatment Phase
  • Drug: Dexmedetomidine 0.5μg/kg
  • Drug: Dexmedetomidine 1μg/kg
Phase 4

Detailed Description

The computer generates random numbers to allocate patients into different group. Trained research staff who are not involved in the study collect the data. The observer who only stayed in PACU was blinded to the allocation and responsible to record the data.

The primary measurement are pain scores, PAED scores, coughing was evaluated on a 9-point scale (1= no coughing, 2= minimal coughing, one or two times, 3-4= moderate coughing, 3-4 times, 5-6= moderate coughing, more than 5 times, 7-8= severe coughing, more than 10 times, 9= laryngospasm), and extubation time. The secondary measurements are the time to discharge from the post-anaesthesia care unit, and the number of postoperative desaturation.

A sample size of 57 was determined by analysis based on the assumption of the decline of extubation time from other similar study and α=0.05,β=0.2.

The continuous variables were presented as means ± SD and the categorical variables were expressed as frequency.

The outcome of interest is extubation time decline.

Study Design

Study Type:
Interventional
Actual Enrollment :
130 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
The Effect of Different Dose of Dexmedetomidine Combined With Hydromorphone in Children With Tonsillectomy and Adenoidectomy
Actual Study Start Date :
Jan 4, 2019
Actual Primary Completion Date :
Feb 10, 2019
Actual Study Completion Date :
Apr 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: group A

Dexmedetomidine(0.5 μg/kg)/hydromophine-based general anesthesia

Drug: Dexmedetomidine 0.5μg/kg
Group A received dexmedetomidine 0.5μg/kg (diluted to 100ml,influded in 5 mins at the beginning of the surgery) and hydromophine 0.03 mg/kg as a bolus.
Other Names:
  • Dexmedetomidine Hydrochloride Injection
  • Experimental: group B

    Dexmedetomidine(1μg/kg)/hydromophine-based general anesthesia

    Drug: Dexmedetomidine 1μg/kg
    Group B received dexmedetomidine 1μg/kg (diluted to 100ml,influded in 5 mins at the beginning of the surgery) and hydromophine 0.03 mg/kg as a bolus.
    Other Names:
  • Dexmedetomidine Hydrochloride Injection
  • Outcome Measures

    Primary Outcome Measures

    1. extubation time [duration from the time that patients arrived in PACU to the time of extubation, though study completion, average 40 mins]

      the time of extubation after surgery

    2. Agitation scores [scores at the time point of 0 minute after extubation]

      pediatric anesthesia emergence delirium (PAED) scores included five behaviors:(1)makes eye contact with caregiver,(2) actions are purposeful,(3) aware of surroundings,(4) restless,(5) inconsolable. Each behavior was correlated to different degree(4= not at all,3= just a little, 2= quite a bit, 1= very much,0= extremely). The scores for each of the five listed behaviors are added to achieve a total score (maximum score of 20, minimum score of 0). A score of >12 is diagnosed to agitation.

    3. Agitation scores [scores at the time point of 5 minutes after extubation]

      pediatric anesthesia emergence delirium (PAED) scores included five behaviors:(1)makes eye contact with caregiver,(2) actions are purposeful,(3) aware of surroundings,(4) restless,(5) inconsolable. Each behavior was correlated to different degree(4= not at all,3= just a little, 2= quite a bit, 1= very much,0= extremely). The scores for each of the five listed behaviors are added to achieve a total score (maximum score of 20, minimum score of 0). A score of >12 is diagnosed to agitation.

    4. Agitation scores [scores at the time point of 10 minutes after extubation]

      pediatric anesthesia emergence delirium (PAED) scores included five behaviors:(1)makes eye contact with caregiver,(2) actions are purposeful,(3) aware of surroundings,(4) restless,(5) inconsolable. Each behavior was correlated to different degree(4= not at all,3= just a little, 2= quite a bit, 1= very much,0= extremely). The scores for each of the five listed behaviors are added to achieve a total score (maximum score of 20, minimum score of 0). A score of >12 is diagnosed to agitation.

    5. Agitation scores [scores at the time point of 15 minutes after extubation]

      pediatric anesthesia emergence delirium (PAED) scores included five behaviors:(1)makes eye contact with caregiver,(2) actions are purposeful,(3) aware of surroundings,(4) restless,(5) inconsolable. Each behavior was correlated to different degree(4= not at all,3= just a little, 2= quite a bit, 1= very much,0= extremely). The scores for each of the five listed behaviors are added to achieve a total score (maximum score of 20, minimum score of 0). A score of >12 is diagnosed to agitation.

    6. coughing score [scores at the time point of 0 minute after extubation]

      a 4-point scale that is used to measure severity of coughing(maximum score of 4, minimum score of 1):1= no coughing,2=minimal coughing, one or two times,3= moderate coughing,3-4 times,4= severe coughing, more than 5 times.

    7. coughing score [scores at the time point of 5 minutes after extubation]

      a 9-point scale (1= no coughing, 2= minimal coughing, one or two times, 3-4= moderate coughing, 3-4 times, 5-6= moderate coughing, more than 5 times, 7-8= severe coughing, more than 10 times, 9= laryngospasm).

    8. coughing score [scores at the time point of 10 minutes after extubation]

      a 9-point scale (1= no coughing, 2= minimal coughing, one or two times, 3-4= moderate coughing, 3-4 times, 5-6= moderate coughing, more than 5 times, 7-8= severe coughing, more than 10 times, 9= laryngospasm).

    9. coughing score [scores at the time point of 15 minutes after extubation]

      a 9-point scale (1= no coughing, 2= minimal coughing, one or two times, 3-4= moderate coughing, 3-4 times, 5-6= moderate coughing, more than 5 times, 7-8= severe coughing, more than 10 times, 9= laryngospasm)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    3 Years to 10 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • experienced tonsillectomy and adenoidectomy

    • ASA physical status I-II

    • weight 12-30 kg

    Exclusion Criteria:
    • respiratory disease

    • circulatory or nervous system disease

    • hepatic dysfunction

    • known adverse reactions to hydromophine and dexmedetomidine

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Anesthesiology Department of Affiliated Eye and ENT Hospital, Fudan University Shanghai Shanghai China 200031

    Sponsors and Collaborators

    • Eye & ENT Hospital of Fudan University

    Investigators

    • Principal Investigator: e ji Jia, M.D., Eye and ENT Hospital of Fudan University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Eye & ENT Hospital of Fudan University
    ClinicalTrials.gov Identifier:
    NCT03760809
    Other Study ID Numbers:
    • dex-hyd
    First Posted:
    Nov 30, 2018
    Last Update Posted:
    Jun 22, 2021
    Last Verified:
    Apr 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Eye & ENT Hospital of Fudan University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 22, 2021